News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

17

2023

-

11

Hazardous waste pollution prevention and control of environmental information publicity

Classification:

News

Corporate News


Company: Shandong Linuo Pharmaceutical Co., Ltd.

Address: 30766 Jingshi East Road, Jinan City, Shandong Province

Legal Representative: Jiang Hongsheng

Hazardous waste generation scale: 10 tons/year

Hazardous waste storage facilities and quantity: 1 hazardous waste temporary storage room

Serial Number

Name of waste

Waste Code

Hazardous Waste Category

generation link

Hazardous characteristics

2023Annual Production (ton)

2023Annual Entrusted Disposal Volume (ton)

whereabouts of hazardous waste

1

expired drugs

900-002-03

HW03

Warehouse/Sales

Toxicity

4.351

4.351

Entrusted Shandong Jinquan Environmental Protection Technology Co., Ltd. to dispose

2

tailings

272-005-02

HW02

Production/Laboratory

Toxicity

1.99148

1.57278

3

Chemical reagent packaging

900-041-49

HW49

Laboratory

Toxicity, flammability, corrosion

0.57094

0.47408

4

Laboratory waste liquid

900-047-49

HW49

Laboratory

Toxicity

0.1983

0.1983

5

expired invalid reagent

900-999-49

HW49

Laboratory

Toxicity

0.11098

0.11098

Management responsible person

Meng Xiang Zheng

Telephone of person responsible for management

13685467267

Publicity time

20231 November of the year

Related news

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

2026-05-18

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.